KZR
Price
$7.49
Change
-$0.03 (-0.40%)
Updated
Nov 15, 03:27 PM (EDT)
118 days until earnings call
WXIBF
Price
$1.86
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

KZR vs WXIBF

Header iconKZR vs WXIBF Comparison
Open Charts KZR vs WXIBFBanner chart's image
Kezar Life Sciences
Price$7.49
Change-$0.03 (-0.40%)
Volume$100
CapitalizationN/A
Wuxi Biologics Cayman
Price$1.86
Change-$0.00 (-0.00%)
Volume$960
CapitalizationN/A
KZR vs WXIBF Comparison Chart
Loading...
KZR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KZR vs. WXIBF commentary
Nov 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KZR is a StrongBuy and WXIBF is a Hold.

COMPARISON
Comparison
Nov 16, 2024
Stock price -- (KZR: $7.52 vs. WXIBF: $1.86)
Brand notoriety: KZR and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KZR: 13% vs. WXIBF: 60%
Market capitalization -- KZR: $54.87M vs. WXIBF: $8.01B
KZR [@Biotechnology] is valued at $54.87M. WXIBF’s [@Biotechnology] market capitalization is $8.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KZR’s FA Score shows that 1 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • KZR’s FA Score: 1 green, 4 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, WXIBF is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KZR’s TA Score shows that 3 TA indicator(s) are bullish.

  • KZR’s TA Score: 3 bullish, 4 bearish.

Price Growth

KZR (@Biotechnology) experienced а +1.48% price change this week, while WXIBF (@Biotechnology) price change was -17.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.98%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +1.57%.

Reported Earning Dates

KZR is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-5.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($8.01B) has a higher market cap than KZR($54.9M). KZR YTD gains are higher at: -20.625 vs. WXIBF (-49.973).
KZRWXIBFKZR / WXIBF
Capitalization54.9M8.01B1%
EBITDAN/AN/A-
Gain YTD-20.625-49.97341%
P/E RatioN/A22.38-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
KZR vs WXIBF: Fundamental Ratings
KZR
WXIBF
OUTLOOK RATING
1..100
396
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9764
PRICE GROWTH RATING
1..100
5753
P/E GROWTH RATING
1..100
10027
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (13) in the Biotechnology industry is somewhat better than the same rating for WXIBF (64) in the null industry. This means that KZR’s stock grew somewhat faster than WXIBF’s over the last 12 months.

KZR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WXIBF (100) in the null industry. This means that KZR’s stock grew similarly to WXIBF’s over the last 12 months.

WXIBF's SMR Rating (64) in the null industry is somewhat better than the same rating for KZR (97) in the Biotechnology industry. This means that WXIBF’s stock grew somewhat faster than KZR’s over the last 12 months.

WXIBF's Price Growth Rating (53) in the null industry is in the same range as KZR (57) in the Biotechnology industry. This means that WXIBF’s stock grew similarly to KZR’s over the last 12 months.

WXIBF's P/E Growth Rating (27) in the null industry is significantly better than the same rating for KZR (100) in the Biotechnology industry. This means that WXIBF’s stock grew significantly faster than KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KZR
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
0%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
KZR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with BHVN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
-0.27%
BHVN - KZR
36%
Loosely correlated
-0.77%
CTMX - KZR
34%
Loosely correlated
-0.99%
PRME - KZR
31%
Poorly correlated
-9.22%
FULC - KZR
30%
Poorly correlated
-6.74%
VRDN - KZR
29%
Poorly correlated
-3.74%
More

WXIBF and

Correlation & Price change

A.I.dvisor tells us that WXIBF and WXXWY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WXIBF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
-17.51%
WXXWY - WXIBF
32%
Poorly correlated
-4.74%
IRON - WXIBF
28%
Poorly correlated
-3.79%
AADI - WXIBF
24%
Poorly correlated
N/A
ELVAF - WXIBF
22%
Poorly correlated
N/A
KZR - WXIBF
20%
Poorly correlated
-0.27%
More